Edition:
United States

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

6.08USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.08
Open
$6.07
Day's High
$6.18
Day's Low
$5.87
Volume
11,548
Avg. Vol
37,824
52-wk High
$21.59
52-wk Low
$4.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.581
FY 2017 Dec '17 0.00 -0.634
Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 2 1.10 2.19 0.00 0.00
Year Ending Dec-18 2 2.19 4.38 0.00 0.83
Year Ending Dec-19 2 4.40 8.80 0.00 4.00
Earnings (per share)
Quarter Ending Jun-18 4 -0.57 -0.47 -0.62 -0.77
Quarter Ending Sep-18 4 -0.70 -0.57 -0.97 -0.91
Year Ending Dec-18 4 -2.39 -1.86 -3.05 -2.48
Year Ending Dec-19 4 -2.68 -1.64 -3.64 -3.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 236.60 32.60
P/E High - Last 5 Yrs. -- 289.72 47.30
P/E Low - Last 5 Yrs. -- 99.63 24.74
Beta -- 0.75 0.79
Price to Sales (TTM) -- 253.19 8.19
Price to Book (MRQ) 4.16 24.02 4.29
Price to Tangible Book (MRQ) 4.16 26.99 5.81
Price to Cash Flow (TTM) -- 135.81 21.74
% Owned Institutions 33.25 10.88 2.45

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.20 0.80
Dividend 5 Year Growth Rate -- 2.27 4.06
Payout Ratio(TTM) -- 46.51 17.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.56 5.07
Sales (TTM) vs TTM 1 Yr. Ago -- 149.10 13.02
Sales - 5 Yr. Growth Rate -- 30.74 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.24 -92.18 35.88
EPS (TTM) vs TTM 1 Yr. Ago -65.63 -- --
EPS - 5 Yr. Growth Rate -- 48.05 8.59
Capital Spending - 5 Yr. Growth Rate -- 39.82 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.53
Current Ratio (MRQ) 5.57 6.57 3.60
LT Debt to Equity (MRQ) 37.28 22.32 12.99
Total Debt to Equity (MRQ) 48.59 25.78 16.09
Interest Coverage (TTM) -19,973.00 -182.04 35.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.26 55.04
Gross Margin - 5 Yr. Avg. -- 55.03 52.82
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -153.84 15.90
Operating Margin (TTM) -- -871.46 0.15
Operating Margin - 5 Yr. Avg. -- -166.48 11.15
Pre-Tax Margin (TTM) -- -758.30 2.24
Pre-Tax Margin - 5 Yr. Avg. -- -171.46 11.36
Net Profit Margin (TTM) -- -750.06 -1.19
Net Profit Margin - 5 Yr. Avg. -- -170.95 7.65
Effective Tax Rate (TTM) -- 14.72 31.40
Effective Tax Rate - 5 Yr. Avg. -- 19.46 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,974,635 724,115,471
Net Income/Employee (TTM) -1,841,278 -947,754 84,106,404
Receivable Turnover (TTM) -- 17.19 5.75
Inventory Turnover (TTM) -- 2.46 3.59
Asset Turnover (TTM) 0.00 0.42 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -102.48 -5.29 10.07
Return on Assets - 5 Yr. Avg. -- -0.38 11.08
Return on Investment (TTM) -123.03 -7.50 12.74
Return on Investment - 5 Yr. Avg. -- 2.94 14.36
Return on Equity (TTM) -143.74 -10.27 14.66
Return on Equity - 5 Yr. Avg. -- -2.81 15.72
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -25.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.24%
# of Holders: 34
Total Shares Held: 4,730,331
3 Mo. Net Change: 1,545,264
# New Positions: 6
# Closed Positions: 9
# Increased Positions: 18
# Reduced Positions: 16
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.